China Renaissance HoldingsChina Renaissance acted as exclusive financial advisor for Gestalt Tech's financing round, generating advisory fee income.
China's first ultrasound brain-computer interface company Gestalt Tech has completed a 420 million yuan angel+ round of financing. This round was led by Huaying Capital, with follow-on investments from C Capital, Sequoia China, Lens Technology, China Electronics Health Fund, Sinovation Ventures, Lingang Sci-Tech Innovation Investment, Fudan Furong Capital, and Guotai Venture Capital, among other leading domestic and international investment institutions. Existing shareholders including Daotong Investment, Yunshi Capital, Qingsong Capital, and Gobi Partners continued to oversubscribe. China Renaissance acted as the exclusive financial advisor. At the same time, Gestalt Tech's Shanghai headquarters in the Brain Intelligence Park in Minhang District was officially inaugurated. As of 14:18 on July 3, 2026, the Shanghai Stock Exchange STAR Biomedical Index rose strongly by 2.69 percent. Among constituent stocks, MGI Tech rose 14.97 percent, Dizal Pharmaceutical rose 10.77 percent, and Olym Biotech rose 8.82 percent, with stocks like Youcare Pharmaceutical and Yundong Biotech also rising. The STAR Medical ETF Huaxia rose 2.17 percent, heading for a fifth consecutive gain, with the latest price at 1.08 yuan. CICC believes that innovative fields represented by AI plus healthcare and brain-computer interfaces are experiencing rapid development, with systems from supporting policies to capital support gradually improving, and such directions may present structural investment opportunities.
China Renaissance HoldingsChina Renaissance acted as exclusive financial advisor for Gestalt Tech's financing round, generating advisory fee income.
Lens Technology Co LtdParticipated as a follow-on investor in Gestalt Tech's financing round.
MGI Tech Co. Ltd. AMGI Tech rose 14.97% as part of a broad rally in STAR Biomedical Index, driven by positive sentiment on AI+healthcare and brain-computer interfaces.
Dizal (Jiangsu) Pharmaceutical Co. Ltd. ADizal Pharmaceutical rose 10.77% as part of a broad rally in STAR Biomedical Index, driven by positive sentiment on AI+healthcare and brain-computer interfaces.
Chengdu Olymvax Biopharmaceuticals Inc. AOlymvax Biopharmaceuticals rose 8.82% as part of a broad rally in STAR Biomedical Index, driven by positive sentiment on AI+healthcare and brain-computer interfaces.
Inner Mongolia Yuan Xing Energy Co Ltd
China International Capital Corp Ltd
Chengdu Easton Biopharmaceuticals Co Ltd
Youcare Pharmaceutical Group Co. Ltd. ACompleted a 420 million yuan angel+ round of financing, a significant capital event for the company.
Participated as a follow-on investor in Gestalt Tech's financing round.
Participated as a follow-on investor in Gestalt Tech's financing round.